Viewing entries in

News

View Post →

Signum presented two posters at this years Society for Investigative Dermatology (SID) meeting in Atlanta Georgia.

May 11, 2015

Signum researchers attended this years Society for Investigative Dermatology (SID). They  presented two posters this year One titled, “SIG1191: A Novel Cosmetic Functional Ingredient with.

View Post →

Signum Biosciences selected to speak at this years American Academy of Neurology (AAN) Conference

Apr 21, 2015

 Signum Biosciences has been selected to present the mechanism and benefits of EHT® at this years American Academy of Neurology Conference (AAN).

View Post →

Signum Biosciences partners with Nerium International and they gain the exclusive usage of SIG-1273, a Revolutionary Anti-Aging Ingredient

Apr 13, 2015

We have partnered with Nerium International, an innovator in age-defying skincare products. Nerium has announced the addition of the groundbreaking new ingredient, SIG-1273®. SIG-1273 is a.

View Post →

Signum Biosciences partner Nerium Interanational introduces new, advanced anti-aging product focused on optimal brain health

Apr 10, 2015

We have partnered with Nerium International,  a leader in scientifically advanced, anti-aging products. Nerium has announced the addition of the groundbreaking new ingredient, EHT®. EHT®, a natural.

View Post →

Signum Dermalogix Out-Licenses SIG990 to Dermata Therapeutics for Topical Treatment of Rosacea

Mar 25, 2015

We have partnered with Dermata Therapeutics, LLC , a private specialty pharmaceutical company developing innovative prescription drugs for dermatological conditions. We have out-Licensed SIG990 to.

View Post →

Signums Scientific Promotions

Oct 1, 2014

Signum announces the promotion of Dr. Jose Fernandez to Director of Research and Development and Eduardo Perez as Chief Scientific Officer. Combined Jose and Eddie have worked at Signum 14 years,.

View Post →

Signum launches ME™ sports the revolutionary brain supplment with EHT™

Aug 4, 2014

ME™ sports is a revolutionary brain supplment with EHT™. Princeton University scientist discovered EHT™, a patented mixture of bioactive molecules derived from coffee. Producing EHT™ starts with a.

View Post →

Signum presents EHT and natural extracts poster at the Protein Phosphatases conference

Jul 25, 2014

See attached document. Signum researchers in collaboration with Princeton University presented a poster titled, “Modulating PP2A Methylation using Natural Extracts”. Here we demonstrate several.

View Post →

Therapeutics benefits of a component of coffee in a rat model of Alzheimer’s Disease

Jun 17, 2014

Signum’s work on the beneficial effects of eicosanoyl-5-hydroxytryptamide has been published in the peer reviewed journal, Neurobiology of Aging. Dr. Khalid Iqbal demonstrates, a component of coffee.

View Post →

Protein phosphatases and Alzheimer's disease.

Feb 26, 2012

See attached document. In a separate article, titled, The Role of Protein Phosphatases and Alzheimer's Disease (AD), Signum reviews recent advances in our understanding of serine/threonine and.

Subscribe Here!